FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362592922> ?p ?o ?g. }

• W4362592922 endingPage "4877" @default.
• W4362592922 startingPage "4877" @default.
• W4362592922 abstract "Abstract Aberrant expression or mutations in core splicing factors including U2AF1, SRSF2, ZRSR2, and SF3B1 found to drive tumorigenesis of various malignant tumors e.g., myelodysplastic syndromes, chronic lymphocytic leukemia, uveal melanoma, and breast cancer. Importantly, the amplifications and mutations in SF3B1, the pioneer splicing factor, are reportedly far more common than those in other splicing factors. However, the functional relevance and underlying mechanisms of dysregulated SF3B1 in endometrial cancer are not investigated. Endometrial cancer is the fourth most common cancer in women in the United States and there will be about 65,950 new endometrial cancer cases in the current year alone with 12,550 estimated cancer deaths in the United States. In this study, we thus investigated the role of SF3B1 in endometrial adenocarcinoma. We found SF3B1 is one of the most frequently amplified or mutated splicing factors in endometrial cancer. Specifically, analysis of The Cancer Genome Atlas (TCGA) uterine pan-cancer dataset revealed that up to 9% of endometrial cancers have SF3B1 mutations or amplification. Additionally, we showed that the SF3B1 protein is overexpressed in human as well as mouse endometrial tumor samples. Further analysis found elevated SF3B1 protein in multiple endometrial cancer cell lines even in the absence of SF3B1 mutations. However, we did not observe any altered expression at the transcript level. Further, we identified a correlation between the over-expressed SF3B1 levels and the tumorigenicity/invasive potential of cancer cell lines. For instance, endometrial cancer cell lines (Ishikawa, AN3CA, KLE) with over-expressed SF3B1 levels were much more tumorigenic and invasive than those with low endogenous SF3B1 levels (normal human endometrial epithelial cells, RL-95-2 cells). Moreover, cell viability assays revealed that Ishikawa, AN3CA, and KLE cells were more susceptible to the loss of SF3B1 or treatment with the SF3B1 inhibitor Pladienolide-B (PLAD-B) than RL-95-2 cells. To further ensure that overexpressed or mutated SF3B1 drives endometrial tumorigenesis, we transiently transfected an empty vector or a vector expressing FLAG-tagged wild-type SF3B1 or vector with mutated SF3B1 construct R957Q into RL-95-2 cells which have minimal endogenous SF3B1. Analysis of proliferation assays revealed that cells overexpressing SF3B1 proliferated significantly more than cells expressing empty vector. Intriguingly, we observed that RL-95-2 cells over-expressing R957Q mutants were even more proliferative than the cells expressing wild-type SF3B1. Together, this data suggest that SF3B1 over-expression and mutation play a crucial oncogenic role in endometrial cancer, and these findings may support the development of SF3B1 inhibitors to treat this disease. Citation Format: Pooja Popli, Xinchao Deng, Premal Thaker, Ramakrishna Kommagani. Mutant or overexpressed SF3B1 facilitates endometrial cancer tumorigenesis. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4877." @default.
• W4362592922 created "2023-04-06" @default.
• W4362592922 creator A5005760526 @default.
• W4362592922 creator A5024497385 @default.
• W4362592922 creator A5064143303 @default.
• W4362592922 creator A5077112092 @default.
• W4362592922 date "2023-04-04" @default.
• W4362592922 modified "2023-09-30" @default.
• W4362592922 title "Abstract 4877: Mutant or overexpressed SF3B1 facilitates endometrial cancer tumorigenesis" @default.
• W4362592922 doi "https://doi.org/10.1158/1538-7445.am2023-4877" @default.
• W4362592922 hasPublicationYear "2023" @default.
• W4362592922 type Work @default.
• W4362592922 citedByCount "0" @default.
• W4362592922 crossrefType "journal-article" @default.
• W4362592922 hasAuthorship W4362592922A5005760526 @default.
• W4362592922 hasAuthorship W4362592922A5024497385 @default.
• W4362592922 hasAuthorship W4362592922A5064143303 @default.
• W4362592922 hasAuthorship W4362592922A5077112092 @default.
• W4362592922 hasConcept C104317684 @default.
• W4362592922 hasConcept C121608353 @default.
• W4362592922 hasConcept C126322002 @default.
• W4362592922 hasConcept C143998085 @default.
• W4362592922 hasConcept C194583182 @default.
• W4362592922 hasConcept C2777088508 @default.
• W4362592922 hasConcept C36823959 @default.
• W4362592922 hasConcept C502942594 @default.
• W4362592922 hasConcept C54355233 @default.
• W4362592922 hasConcept C555283112 @default.
• W4362592922 hasConcept C71924100 @default.
• W4362592922 hasConcept C73758832 @default.
• W4362592922 hasConcept C86803240 @default.
• W4362592922 hasConceptScore W4362592922C104317684 @default.
• W4362592922 hasConceptScore W4362592922C121608353 @default.
• W4362592922 hasConceptScore W4362592922C126322002 @default.
• W4362592922 hasConceptScore W4362592922C143998085 @default.
• W4362592922 hasConceptScore W4362592922C194583182 @default.
• W4362592922 hasConceptScore W4362592922C2777088508 @default.
• W4362592922 hasConceptScore W4362592922C36823959 @default.
• W4362592922 hasConceptScore W4362592922C502942594 @default.
• W4362592922 hasConceptScore W4362592922C54355233 @default.
• W4362592922 hasConceptScore W4362592922C555283112 @default.
• W4362592922 hasConceptScore W4362592922C71924100 @default.
• W4362592922 hasConceptScore W4362592922C73758832 @default.
• W4362592922 hasConceptScore W4362592922C86803240 @default.
• W4362592922 hasIssue "7_Supplement" @default.
• W4362592922 hasLocation W43625929221 @default.
• W4362592922 hasOpenAccess W4362592922 @default.
• W4362592922 hasPrimaryLocation W43625929221 @default.
• W4362592922 hasRelatedWork W1499339123 @default.
• W4362592922 hasRelatedWork W2065690661 @default.
• W4362592922 hasRelatedWork W2117059884 @default.
• W4362592922 hasRelatedWork W2321791250 @default.
• W4362592922 hasRelatedWork W2467622083 @default.
• W4362592922 hasRelatedWork W2487824964 @default.
• W4362592922 hasRelatedWork W2769390123 @default.
• W4362592922 hasRelatedWork W2984941165 @default.
• W4362592922 hasRelatedWork W3215103363 @default.
• W4362592922 hasRelatedWork W4323808922 @default.
• W4362592922 hasVolume "83" @default.
• W4362592922 isParatext "false" @default.
• W4362592922 isRetracted "false" @default.
• W4362592922 workType "article" @default.